Cyril Ramaphosa says results of the first trials for HIV/Aids vaccine trials are expected to be released by 2022. CAPE TOWN - Deputy President Cyril Ramaphosa says R135 million will be spent on the country's HIV/Aids vaccine trial rollout.Ramaphosa is addressing the National Council of Provinces this afternoon where he is elaborating on his role as the leader of government business as well as other responsibilities assigned to him by President Jacob Zuma.Ramaphosa says results of the first trials for HIV/Aids vaccine trials are expected to be released by 2022. Scientists expects the vaccine to be at least 50% effective, but hope that it d be much more. The leading role that South Africa is playing in vaccine research is the results of ongoing investment in HIV vaccine development over many years. (Edited by Zamangwane Shange)